Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP305882.RA5NfjMn9k5O0qAV6j0jkoq9GxsuVdNVMVnvZ4cnaVWeo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP305882.RA5NfjMn9k5O0qAV6j0jkoq9GxsuVdNVMVnvZ4cnaVWeo130_assertion type Assertion NP305882.RA5NfjMn9k5O0qAV6j0jkoq9GxsuVdNVMVnvZ4cnaVWeo130_head.
- NP305882.RA5NfjMn9k5O0qAV6j0jkoq9GxsuVdNVMVnvZ4cnaVWeo130_assertion wasGeneratedBy ECO_0000203 NP305882.RA5NfjMn9k5O0qAV6j0jkoq9GxsuVdNVMVnvZ4cnaVWeo130_provenance.
- NP305882.RA5NfjMn9k5O0qAV6j0jkoq9GxsuVdNVMVnvZ4cnaVWeo130_assertion wasDerivedFrom befree-20140225 NP305882.RA5NfjMn9k5O0qAV6j0jkoq9GxsuVdNVMVnvZ4cnaVWeo130_provenance.
- NP305882.RA5NfjMn9k5O0qAV6j0jkoq9GxsuVdNVMVnvZ4cnaVWeo130_assertion SIO_000772 22525818 NP305882.RA5NfjMn9k5O0qAV6j0jkoq9GxsuVdNVMVnvZ4cnaVWeo130_provenance.
- NP305882.RA5NfjMn9k5O0qAV6j0jkoq9GxsuVdNVMVnvZ4cnaVWeo130_assertion evidence source_evidence_literature NP305882.RA5NfjMn9k5O0qAV6j0jkoq9GxsuVdNVMVnvZ4cnaVWeo130_provenance.
- NP305882.RA5NfjMn9k5O0qAV6j0jkoq9GxsuVdNVMVnvZ4cnaVWeo130_assertion description "[The combined treatment with anti-miR-155 and losartan has a synergistic antiproliferative effect and an improved understanding is required to clarify whether miR-155 and AGTR1 can be used as a novel therapeutic target in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP305882.RA5NfjMn9k5O0qAV6j0jkoq9GxsuVdNVMVnvZ4cnaVWeo130_provenance.